Genetic test could predict heart risk before it strikes

NCT ID NCT06542432

ENROLLING_BY_INVITATION Knowledge-focused Sponsor: MyOme Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study looks at whether giving people a personalized genetic risk score for coronary artery disease helps doctors make better decisions about prevention. About 1,000 adults with moderate heart risk will be randomly assigned to receive their risk score or not. Researchers will track if the score leads to more use of cholesterol-lowering drugs or heart tests, and whether it lowers cholesterol levels or heart attacks over time.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

polygenic risk score (genetic test)

What this could lead to

If successful, this could help doctors identify people at higher risk for heart disease earlier and guide preventive treatments like cholesterol-lowering medications.

What could go wrong

This is an observational study, not a treatment trial. The risk score may not significantly change doctor behavior or improve health outcomes, and results may not apply to all populations.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CARDIOVASCULAR DISEASES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cardiovascular disorder coronary artery disorder Coronary Disease Genetic Risk Score heart disorder myocardial infarction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Mayo Clinic

    Rochester, Minnesota, 55905, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States